CXCL16 and chronic kidney disease: Recent work has identified CXCL16-CXCR6 signaling as the mediator of group 3 innate lymphoid cell accumulation in the kidney during renal fibrosis and chronic kidney disease, supporting a function of CXCR6 in kidney immune responses during persistent/chronic inflammation [39].